rabbit polyclonal primary antibodies against insulin receptor β subunit (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
96
Structured Review
Cell Signaling Technology Inc
rabbit polyclonal primary antibodies against insulin receptor β subunit
Rabbit Polyclonal Primary Antibodies Against Insulin Receptor β Subunit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 527 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+primary+antibodies+against+insulin+receptor+%CE%B2+subunit/Insulin+Receptor+beta+Rabbit+mAb/pm38750806-187-26-34
Average 96 stars, based on 527 article reviews
Rabbit Polyclonal Primary Antibodies Against Insulin Receptor β Subunit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 527 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+primary+antibodies+against+insulin+receptor+%CE%B2+subunit/Insulin+Receptor+beta+Rabbit+mAb/pm38750806-187-26-34
Average 96 stars, based on 527 article reviews
rabbit polyclonal primary antibodies against insulin receptor β subunit - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Electrophoresis:Article Title: Intranasal insulin treatment ameliorates spatial memory, muscular strength, and frailty deficits in 5xFAD mice. Article Snippet: The 5xFAD mouse model shows age-related weight loss as well as cognitive and motor deficits.. Metabolic dysregulation, especially impaired insulin signaling, is also present in AD.. This study examined whether intranasal delivery of insulin (INI) at low (0.875 U) or high (1.750 U) doses would ameliorate these deficits compared to saline in 10-month-old female 5xFAD and B6SJL wildtype (WT) mice. Incubation:Article Title: Intranasal insulin treatment ameliorates spatial memory, muscular strength, and frailty deficits in 5xFAD mice. Article Snippet: The 5xFAD mouse model shows age-related weight loss as well as cognitive and motor deficits.. Metabolic dysregulation, especially impaired insulin signaling, is also present in AD.. This study examined whether intranasal delivery of insulin (INI) at low (0.875 U) or high (1.750 U) doses would ameliorate these deficits compared to saline in 10-month-old female 5xFAD and B6SJL wildtype (WT) mice. Blocking Assay:Article Title: Intranasal insulin treatment ameliorates spatial memory, muscular strength, and frailty deficits in 5xFAD mice. Article Snippet: The 5xFAD mouse model shows age-related weight loss as well as cognitive and motor deficits.. Metabolic dysregulation, especially impaired insulin signaling, is also present in AD.. This study examined whether intranasal delivery of insulin (INI) at low (0.875 U) or high (1.750 U) doses would ameliorate these deficits compared to saline in 10-month-old female 5xFAD and B6SJL wildtype (WT) mice. |